Synapse

← The Lancet Regional Health - Europe

Papers in The Lancet Regional Health - Europe

Page 4 · newest first

  1. Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (BeNeBio study): An International, Pragmatic, Multicentre, Randomised, Controlled, Non-Inferiority TrialThe Lancet Regional Health - Europe · 2026
  2. Assessing Europe's Policy Readiness to Confront the MASLD/MASH Public Health ThreatThe Lancet Regional Health - Europe · 2026
  3. From Targets to Real World Impact: A Review of Models of Care for Chronic HBV and HCV in EuropeThe Lancet Regional Health - Europe · 2026
  4. Ending the Chronic Liver Disease Public Health Threat: Systemic Challenges Through the Patient LensThe Lancet Regional Health - Europe · 2026
  5. A global commitment to addressing chronic liver diseaseThe Lancet Regional Health - Europe · 2026
  6. Implementation of evidence-based alcohol policies to reduce alcohol-related harm and liver disease to advance public health in EuropeThe Lancet Regional Health - Europe · 2026
  7. Diagnostic Innovation and Models of Care to Improve Fibrosis Detection and Risk Stratification in Steatotic Liver DiseaseThe Lancet Regional Health - Europe · 2026
  8. European Congress of Endocrinology (ECE) 2026The Lancet Regional Health - Europe · 2026
  9. Closing the Implementation Gap: New Models of Care to End Chronic Liver DiseaseThe Lancet Regional Health - Europe · 2026
  10. Diagnostic Implications of Multi-Cancer Early Detection Testing in the Investigation of Cancer Symptoms: An Exploratory Retrospective Analysis of the SYMPLIFY StudyThe Lancet Regional Health - Europe · 2026
  11. Metabolic Trajectories Before Diabetes Diagnosis Across Subgroups: A Pooled Analysis of Prospective European Cohort StudiesThe Lancet Regional Health - Europe · 2026
  12. The MV Hondius Warning: Hantavirus Surveillance Blind SpotsThe Lancet Regional Health - Europe · 2026
  13. Effectiveness and Safety of Semaglutide in Type 1 Diabetes: A Danish Nationwide Cohort Study (2018–2024)The Lancet Regional Health - Europe · 2026
  14. Group B streptococcal disease in infants 0–3 months in The Netherlands, 1987–2023: a nationwide genomic and epidemiological surveillance studyThe Lancet Regional Health - Europe · 2026
  15. Efficacy and Safety Evidence Supporting Cancer Drug Approvals in Switzerland (2001–2020): A Meta-Analysis of Pivotal Randomised Controlled TrialsThe Lancet Regional Health - Europe · 2026
  16. Incidence and Clinical, Virological, and Resistance Characteristics of HIV Infections Among pre-Exposure Prophylaxis Users in Spain (SCOPE Study): A Multicentre Prospective and Retrospective Cohort StudyThe Lancet Regional Health - Europe · 2026
  17. Lipid-Lowering Treatment in Familial Hypercholesterolaemia, 1996–2021: A Nationwide StudyThe Lancet Regional Health - Europe · 2026
  18. Long-term clinical and cost-effectiveness of a fully automated digital cognitive behavioural therapy for insomnia: 2-year follow-up of a single-blind, superiority, randomised controlled trialThe Lancet Regional Health - Europe · 2026
  19. Safety and efficiency of peanut oral immunotherapy in preschool children with slow up-dosing and low maintenance dosing: a randomised controlled trialThe Lancet Regional Health - Europe · 2026
  20. Primary Human Papillomavirus Screening Versus Cytology for Detection of Cervical Intraepithelial Neoplasia Grade 2 or Higher in Poland: a Parallel-Group, Randomized Controlled TrialThe Lancet Regional Health - Europe · 2026
  21. Absolute risk of acquired brain injury and rehabilitation needs in Denmark, 2014–2023: a population-based prospective cohort studyThe Lancet Regional Health - Europe · 2026
  22. Clinical outcomes and remission trajectories in obese and non-obese patients with severe asthma treated with biologics: a retrospective longitudinal cohort study from the Severe Asthma Network Italy (SANI) registryThe Lancet Regional Health - Europe · 2026
  23. Fosfomycin versus ciprofloxacin for febrile neutropenia prophylaxis in high-risk haematological patients (FOVOCIP): a phase 3, open-label, multicentre, randomised, non-inferiority trialThe Lancet Regional Health - Europe · 2026
  24. Biopsy with same-session MRI-guided laser interstitial thermal therapy versus biopsy alone in patients with primary unresectable glioblastoma: a multicentre randomised controlled trialThe Lancet Regional Health - Europe · 2026
  25. Beyond regulation: why Europe must lead AI stewardship in healthThe Lancet Regional Health - Europe · 2026
  26. The Swedish welfare state under threat: new rules and new inequalitiesThe Lancet Regional Health - Europe · 2026
  27. Trends in mortality and years of life lost among patients with cirrhosis and hepatocellular carcinoma in France, 2011–2023: a nationwide retrospective population-based studyThe Lancet Regional Health - Europe · 2026
  28. Trends in sudden death-attributed mortality across Europe, 2010–2020: a retrospective population-based analysisThe Lancet Regional Health - Europe · 2026
  29. The case for primary prevention of obesity in the era of GLP-1 therapiesThe Lancet Regional Health - Europe · 2026
  30. Progress and challenges in seasonal influenza vaccination across 54 countries and areas in the WHO European Region, 2008/09–2022/23: a repeated cross-sectional ecological studyThe Lancet Regional Health - Europe · 2026
  31. Adjunctive betamethasone treatment of hypoxaemic adults hospitalised with Mycoplasma pneumoniae community-acquired pneumonia: an open-label, multicentre, randomised, controlled trialThe Lancet Regional Health - Europe · 2026
  32. Corticosteroids for Mycoplasma pneumoniae community-acquired pneumonia: promising evidence from a randomised controlled trialThe Lancet Regional Health - Europe · 2026
  33. Real-world presentation and outcomes of gastroenteropancreatic neuroendocrine neoplasms in Italy: findings from the nationwide Itanet prospective databaseThe Lancet Regional Health - Europe · 2026
  34. Peripheral intravenous catheter use in French emergency departments (CathIRU study): a multicentre cross-sectional study of non-indicated insertion rate and practice patternsThe Lancet Regional Health - Europe · 2026
  35. Treatment outcomes and long-term relapse-free survival after multidrug-resistant tuberculosis treatment in Latvia: a retrospective national cohort studyThe Lancet Regional Health - Europe · 2026
  36. Psychiatric inpatient bed capacity and suicide mortality in Sweden: a nationwide ecological studyThe Lancet Regional Health - Europe · 2026
  37. Spatiotemporal dynamics of leptospirosis in Europe: a retrospective observational study with prospective projectionsThe Lancet Regional Health - Europe · 2026
  38. Implementation and effectiveness of the WHO Self-Help Plus (SH+) intervention in the Gaza Strip: a prospective hybrid type 1 non-randomised studyThe Lancet Regional Health - Europe · 2026
  39. Mortality in children aged 0–14 years born to immigrant parents in Sweden: a total-population cohort studyThe Lancet Regional Health - Europe · 2026
  40. Inequalities in childhood pneumococcal conjugate vaccine uptake in England before and after the change from a 2 + 1 to 1 + 1 schedule: a longitudinal studyThe Lancet Regional Health - Europe · 2026
  41. Bivalent RSV prefusion vaccine effectiveness against hospitalisation in older adults: meta-analysis of case–control studies in England, Wales, Scotland, and Northern IrelandThe Lancet Regional Health - Europe · 2026
  42. Socioeconomic disparities in treatment and survival of oesophageal and gastric cancer in the Netherlands: a nationwide population-based studyThe Lancet Regional Health - Europe · 2026
  43. Liver cirrhosis and hepatocellular carcinoma attributable to hepatitis B and C in Kyrgyzstan, 2019–2024: a prospective and retrospective studyThe Lancet Regional Health - Europe · 2026
  44. Personality and mental health as mediators linking childhood maltreatment to intimate partner violence victimization: a Mendelian randomization–direction of causation twin studyThe Lancet Regional Health - Europe · 2026
  45. Mental well-being in 15–19-year-old adolescents and poor school connectedness, dropout, and NEET status: a prospective cohort studyThe Lancet Regional Health - Europe · 2026
  46. Epidemiological trends in abdominal trauma in Norway (2015–2023): a national register-based cohort study of severity, population-adjusted incidence, and short-term outcomesThe Lancet Regional Health - Europe · 2026
  47. Prescription psychostimulants or atomoxetine and the risk of stimulant-related hospital admissions in adults with and without stimulant use disorder: a Swedish population-based within-individual observational studyThe Lancet Regional Health - Europe · 2026
  48. Clinical presentation and hospitalisation risk of RSV in primary care among children younger than 5 years in Italy in four seasons between 2019 and 2023: a multicentre prospective cohort studyThe Lancet Regional Health - Europe · 2026
  49. Association between changes in adherence to the planetary health diet and adiposity and body fat distribution: a cohort studyThe Lancet Regional Health - Europe · 2026
  50. Time to diagnosis and treatment of obstructive sleep apnoea using mandibular jaw movement monitoring versus polysomnography: an open-label, multicentre, randomised, controlled trialThe Lancet Regional Health - Europe · 2026